Zeng Y - Search Results

1

CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer.

Zeng Y, Liu Q, Wang Y, Tian C, Yang Q, Zhao Y, Liu L, Wu G, Xu S. Zeng Y, et al. Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):758-769. doi: 10.1016/j.ijrobp.2020.05.005. Epub 2020 May 12. Int J Radiat Oncol Biol Phys. 2020. PMID: 32407930 Free article.

2

Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report.

Liang JY, Tong F, Gu FF, Liu YY, Zeng YL, Hong XH, Zhang K, Liu L. Liang JY, et al. Medicine (Baltimore). 2017 May;96(21):e6985. doi: 10.1097/MD.0000000000006985. Medicine (Baltimore). 2017. PMID: 28538405 Free PMC article.

3

Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma.

Liu Y, Hu Y, Gu F, Liang J, Zeng Y, Hong X, Zhang K, Liu L. Liu Y, et al. Among authors: zeng y. Oncotarget. 2017 Jun 28;8(53):90969-90978. doi: 10.18632/oncotarget.18771. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207617 Free PMC article.

4

Application of dynamic monitoring of genomic profiles in non-small cell lung cancer: A case report.

Kuang BH, Wang BC, Tong F, Yang JS, Zeng YL, Cao RB, Liu L. Kuang BH, et al. Medicine (Baltimore). 2018 Dec;97(51):e13192. doi: 10.1097/MD.0000000000013192. Medicine (Baltimore). 2018. PMID: 30572427 Free PMC article.

5

Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer.

Liu YY, Yang QF, Yang JS, Cao RB, Liang JY, Liu YT, Zeng YL, Chen S, Xia XF, Zhang K, Liu L. Liu YY, et al. Int J Cancer. 2019 Sep 1;145(5):1423-1431. doi: 10.1002/ijc.32145. Epub 2019 Jan 31. Int J Cancer. 2019. PMID: 30664810

6

FOXA1⁺ regulatory T cells: A novel T cell subset that suppresses antitumor immunity in lung cancer.

Liang J, Tian C, Zeng Y, Yang Q, Liu Y, Liu Y, Wu J, Hu Y, Gu F, Zhang K, Wang Y, Zhang Y, Liu L. Liang J, et al. Among authors: zeng y. Biochem Biophys Res Commun. 2019 Jun 18;514(1):308-315. doi: 10.1016/j.bbrc.2019.04.152. Epub 2019 Apr 26. Biochem Biophys Res Commun. 2019. PMID: 31036318 Free article.

7

Clinical value of MLH1-negative circulating tumor cells in lung cancer patients.

Liang JY, Yang QF, Zeng YL, Liu YY, Liu YT, Gu FF, Hu Y, Zhang K, Zhong H, Liu L. Liang JY, et al. Among authors: zeng yl. Medicine (Baltimore). 2019 Jun;98(25):e15721. doi: 10.1097/MD.0000000000015721. Medicine (Baltimore). 2019. PMID: 31232917 Free PMC article.

8

The Superior Ability of Human BDCA3⁺ (CD141⁺) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells.

Gu FF, Zhang K, Ma LL, Liu YY, Li C, Hu Y, Yang QF, Liang JY, Zeng YL, Wang Y, Liu L. Gu FF, et al. Among authors: zeng yl. Front Immunol. 2020 Jun 19;11:1267. doi: 10.3389/fimmu.2020.01267. eCollection 2020. Front Immunol. 2020. PMID: 32655564 Free PMC article.

9

Identification of Clonal Neoantigens Derived From Driver Mutations in an EGFR-Mutated Lung Cancer Patient Benefitting From Anti-PD-1.

Wu D, Liu Y, Li X, Liu Y, Yang Q, Liu Y, Wu J, Tian C, Zeng Y, Zhao Z, Xiao Y, Gu F, Zhang K, Hu Y, Liu L. Wu D, et al. Among authors: zeng y. Front Immunol. 2020 Jul 23;11:1366. doi: 10.3389/fimmu.2020.01366. eCollection 2020. Front Immunol. 2020. PMID: 32793190 Free PMC article.

10

IQGAP3 interacts with Rad17 to recruit the Mre11-Rad50-Nbs1 complex and contributes to radioresistance in lung cancer.

Zeng Y, Jie X, Wu B, Wu G, Liu L, Xu S. Zeng Y, et al. Cancer Lett. 2020 Nov 28;493:254-265. doi: 10.1016/j.canlet.2020.08.042. Epub 2020 Sep 4. Cancer Lett. 2020. PMID: 32896617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,630 results

Search Page

Filters